Taft Stettinius & Hollister has been recognized as one of the top defense firms for ANDA litigation in Lex Machina’s 2018 Hatch-Waxman/ANDA Litigation Report. Taft is included on the list of “Top law firms by cases filed 2016-2017 representing defendants,” with 30 cases. The fourth annual report mines legal analytics to look for trends and insights into pharmaceutical patent litigation.

Taft has one of the premier Hatch-Waxman Litigation practices in the nation, combining several decades of experience among its trial lawyers, Ph.D.-level scientific advisors and staff. Led by Stephen R. Auten, the team has been involved in more than 100 ANDA patent litigations over the years and numerous others relating to 505(b)(2) applications.

“We’re very thankful that our generic drug clients allow us to partner with them in their efforts to bring affordable, high-quality medicines to the U.S. market,” said Auten, chair of Taft’s Pharmaceutical & Life Sciences group.